Cargando…
Effectiveness and safety of direct oral anticoagulants in atrial fibrillation patients switched from vitamin K antagonists: A systematic review and meta‐analysis
A substantial proportion of atrial fibrillation patients initiating direct oral anticoagulants (DOAC) are vitamin K antagonists (VKA)‐experienced, for example switchers from VKA to DOAC. With this study, we aimed to summarize available evidence on the effectiveness and safety of DOAC vs VKA in real‐...
Autores principales: | Hellfritzsch, Maja, Adelborg, Kasper, Damkier, Per, Paaske Johnsen, Søren, Hallas, Jesper, Pottegård, Anton, Grove, Erik Lerkevang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973083/ https://www.ncbi.nlm.nih.gov/pubmed/31240841 http://dx.doi.org/10.1111/bcpt.13283 |
Ejemplares similares
-
Clinical events preceding switching and discontinuation of oral anticoagulant treatment in patients with atrial fibrillation
por: Hellfritzsch, Maja, et al.
Publicado: (2017) -
Persistence and adherence to non-vitamin K antagonist oral anticoagulant treatment in patients with atrial fibrillation across five Western European countries
por: Komen, Joris J, et al.
Publicado: (2021) -
Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds
por: Komen, Joris, et al.
Publicado: (2022) -
Congenital Malformations in Denmark: Considerations for the Use of Danish Health Care Registries
por: Broe, Anne, et al.
Publicado: (2020) -
Life-Threatening Contraceptive-Related Pulmonary Embolism in a 14-Year-Old Girl with Hereditary Thrombophilia
por: Hellfritzsch, Maja, et al.
Publicado: (2015)